Event Brief
Aug 5, 2026 at 9:06 AM ET
Lilly revenue rises 48% on strong GLP-1 demand
By The BriefBrief
Eli Lilly reported sales growth driven by higher-than-expected demand for Mounjaro and Zepbound.
WHO: Eli Lilly
WHAT: Lilly reported revenue up 48%, driven by demand for its GLP-1 drugs Mounjaro and Zepbound
WHEN: Reported Aug 5, 2026 at 8:01 AM ET
WHERE: USA
WHY: Higher-than-expected demand for Mounjaro and Zepbound drove sales.
Reporting from 2 identified publishers across this event arc.
View all 2 publishers
Publishers represented across this event arc
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Iran, Oman, US ‘close’ to Hormuz shipping deal
Iran
Aug 5, 2026 at 9:08 AM ET
Trump hints Strait of Hormuz deal could be near
World
Aug 5, 2026 at 9:06 AM ET
Progressive William Lawrence wins Democratic primary
William Lawrence
Aug 5, 2026 at 9:06 AM ET
DC National Guard mission ends first year
Us
Aug 5, 2026 at 9:06 AM ET
Page 10759 of 21436
Same format. Every time.
Continue reading — sign in or create a free account with
